Use of Central Venous Catheter-Related Bloodstream Infection Prevention Practices by US Hospitals

Krein, Sarah L.; Hofer, Timothy P.; Kowalski, Christine P.; Olmsted, Russell N.; Kauffman, Carol A.; Forman, Jane H.; Banaszak-Holl, Jane; Saint, Sanjay
June 2007
Mayo Clinic Proceedings;Jun2007, Vol. 82 Issue 6, p672
Academic Journal
OBJECTIVE: To examine the extent to which US acute care hospitals have adopted recommended practices to prevent central venous catheter-related bloodstream infections (CR-BSis). PARTICIPANTS AND METHODS: Between March 16, 2005, and August 1, 2005, a survey of infection control coordinators was conducted at a national random sample of nonfederal hospitals with an intensive care unit and more than 50 hospital beds (n=600) and at all Department of Veterans Affairs (VA) medical centers (n=119). Primary outcomes were regular use of 5 specific practices and a composite approach for preventing CR-BSis. RESULTS: The overall survey response rate was 72% (n=516). A higher percentage of VA compared to non-VA hospitals reported using maximal sterile barrier precautions (84% vs 71%; P=.01); chlorhexidine gluconate for insertion site antisepsis (91% vs 69%; P<.001); and a composite approach (62% vs 44%; P=.003) combining concurrent use of maximal sterile barrier precautions, chlorhexidine gluconate, and avoidance of routine central line changes. Those hospitals having a higher safety culture score, having a certified infection control professional, and participating in an infection prevention collaborative were more likely to use CR-BSI prevention practices. CONCLUSION: Most US hospitals are using maximal sterile barrier precautions and chlorhexidine gluconate, 2 of the most strongly recommended practices to prevent CR-BSIs. However, fewer than half of non-VA US hospitals reported concurrent use of maximal sterile barrier precautions, chlorhexidine gluconate, and avoidance of routine central line changes. Wider use of CR-BSI prevention practices by hospitals could be encouraged by fostering a culture of safety, participating in infection prevention collaboratives, and promoting infection control professional certification.


Related Articles

  • Should We Teach Every Soldier How to Start an IV? Mabry, Robert L.; Cuanca, Peter J. // Military Medicine;Jun2009, Vol. 174 Issue 6, preceding p557 

    The author talks about the necessity of requiring U.S. soldiers to be competent in placing an intravenous (IV) line and initiating treatment with IV fluids under the existing combat lifesaver (CLS) standards. He argues that such requirement may not be the best use of training resources as IV...

  • Cardiac troponin I release and cytokine response during experimental human endotoxaemia. van Bockel, Esther A. P.; Tulleken, Jaap E.; Muller Kobold, Anneke C.; Ligtenberg, Jack J. M.; van der Werf, Tjip S.; Spanjersberg, Rob; Zijlstra, Jan G. // Intensive Care Medicine;Sep2003, Vol. 29 Issue 9, p1598 

    Objective: To study the relationship between cytokine levels and cardiac troponin I (cTnI).Design: Prospective experimental study.Setting: Intensive care unit of a university hospital.Participants: Six healthy male volunteers. INTERVENTIONS....

  • Programmable Infusion Pumps in ICUs: An Analysis of Corresponding Adverse Drug Events. Nuckols, Teryl K.; Bower, Anthony G.; Paddock, Susan M.; Hilborne, Lee H.; Wallace, Peggy; Rothschild, Jeffrey M.; Griffin, Anne; Fairbanks, Rollin J.; Carlson, Beverly; Panzer, Robert J.; Brook, Robert H. // JGIM: Journal of General Internal Medicine;Jan2008 Supplement 1, Vol. 23 Issue S1, p41 

    Patients in intensive care units (ICUs) frequently experience adverse drug events involving intravenous medications (IV-ADEs), which are often preventable. To determine how frequently preventable IV-ADEs in ICUs match the safety features of a programmable infusion pump with safety software...

  • Centralization of paediatric intensive care: are critically ill children appropriately referred to a regional centre? Goh, Adrian Y.; Mok, Quen; Goh, A Y; Mok, Q // Intensive Care Medicine;Apr2001, Vol. 27 Issue 4, p730 

    Objectives: To evaluate the appropriateness of emergency referrals for inter-hospital transfers by local physicians in hospitals without intensive care facilities to a regional tertiary paediatric intensive care unit (PICU).Design: A prospective, descriptive study in a...

  • Vascular access devices: securement and dressings. Gabriel, Janice // Nursing Standard;9/1/2010, Vol. 24 Issue 52, p41 

    Many patients admitted to hospital will require a vascular access device (VAD). Insertion of VADs is often viewed as a routine procedure, with little attention given to the importance of appropriate securement and dressing and how these factors can affect patient outcomes. This article discusses...

  • Complications associated with venous access devices: part two. Hamilton, Helen // Nursing Standard;3/15/2006, Vol. 20 Issue 27, p59 

    In the second of two articles the author discusses the secondary complications that can arise following insertion of venous access devices (VADs). Part one, published last week, examined the primary complications that can arise when inserting VADs.

  • Central venous access devices Part 1: devices for acute care. Scales, Katie // British Journal of Nursing;1/28/2010, Vol. 19 Issue 2, p88 

    This two-part article provides an overview of central venous access devices (CVADs) for acute and longer-term use. Part 1 reviews the classifications of vascular access devices before focusing on CVADs for the acute care setting. The rationale for selecting the central route is explained....

  • Patients With Hematological Disorders Requiring Admission To Medical Intensive Care Unit In A Developing Country: Characteristics, Survival And Prognostic Factors. Subhash, H.S.; George, Biju; Devi, A.; John, George; Chandy, Mammen; Srivastava, Alok // Internet Journal of Emergency & Intensive Care Medicine;2004, Vol. 7 Issue 2, p1 

    This retrospective study assessed the characteristics and outcome of patients with hematological disorders who required admission to medical intensive care unit over a 4 year period from January 1998 to December 2001. 104 patients were studied, 67 (64%) males and 37 (36%) females with a mean age...

  • Artesunate for Imported Severe Malaria in Nonendemic Countries. Jaur├ęguiberry, St├ęphane; Thellier, Marc; Caumes, Eric; Buffet, Pierre; Kurth, Florian; Zoller, Thomas // Clinical Infectious Diseases;1/15/2016, Vol. 62 Issue 2, p270 

    A letter to the editor is presented in response to the article "Intravenous artesunate reduces parasite clearance time, duration of intensive care, and hospital treatment in patients with severe malaria in Europe: the TropNet severe malaria study" by F. Kurth and others in a 2015 issue.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics